APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $334,153 | +12.1% | 5,066 | -12.1% | 0.02% | +30.8% |
Q4 2022 | $298,005 | -22.5% | 5,763 | +2.3% | 0.01% | -31.6% |
Q3 2022 | $384,666 | +55.2% | 5,632 | +2.7% | 0.02% | +72.7% |
Q2 2022 | $247,896 | -0.3% | 5,482 | +12.0% | 0.01% | +22.2% |
Q1 2022 | $248,664 | -71.4% | 4,894 | -73.4% | 0.01% | -25.0% |
Q4 2021 | $870,236 | +49.5% | 18,406 | +4.2% | 0.01% | +50.0% |
Q3 2021 | $581,975 | -47.0% | 17,657 | +1.7% | 0.01% | -46.7% |
Q2 2021 | $1,097,531 | +57.0% | 17,366 | +6.6% | 0.02% | +50.0% |
Q1 2021 | $699,133 | -28.7% | 16,293 | -5.0% | 0.01% | -33.3% |
Q4 2020 | $981,152 | +77.3% | 17,153 | -6.5% | 0.02% | +50.0% |
Q3 2020 | $553,318 | -7.6% | 18,340 | 0.0% | 0.01% | -9.1% |
Q2 2020 | $598,984 | +22.8% | 18,340 | +0.7% | 0.01% | +10.0% |
Q1 2020 | $487,739 | -1.2% | 18,206 | +12.9% | 0.01% | +25.0% |
Q4 2019 | $493,901 | +27.1% | 16,130 | 0.0% | 0.01% | +14.3% |
Q3 2019 | $388,572 | +17.4% | 16,130 | +23.5% | 0.01% | +16.7% |
Q2 2019 | $330,915 | +38.9% | 13,059 | +6.9% | 0.01% | +50.0% |
Q1 2019 | $238,212 | +47.8% | 12,216 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $161,129 | -25.8% | 12,216 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $217,200 | -99.8% | 12,216 | +203.9% | 0.00% | +300.0% |
Q1 2018 | $88,882,000 | – | 4,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |